U.S. Markets close in 12 mins.

Nymox Pharmaceutical Corporation (NYMX)


NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
3.93-0.05 (-1.26%)
As of 3:47PM EDT. Market open.
People also watch
SPHSEBIOPBMDCYCCNVGN
Full screen
Previous Close3.98
Open3.97
Bid3.91 x 900
Ask3.93 x 200
Day's Range3.91 - 4.05
52 Week Range1.62 - 5.79
Volume77,547
Avg. Volume255,280
Market Cap198.26M
Beta1.39
PE Ratio (TTM)-14.83
EPS (TTM)N/A
Earnings DateN/A
Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Trade prices are not sourced from all markets
  • Capital Cube21 days ago

    ETFs with exposure to Nymox Pharmaceutical Corp. : July 4, 2017

    Categories: ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to Nymox Pharmaceutical Corp. Here are 5 ETFs with the largest exposure to NYMX-US. Comparing the performance and risk of Nymox Pharmaceutical Corp. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker ... Read more (Read more...)

  • Nymox Pharmaceutical Corp. :NYMX-US: Earnings Analysis: Q1, 2017 By the Numbers : May 24, 2017
    Capital Cube2 months ago

    Nymox Pharmaceutical Corp. :NYMX-US: Earnings Analysis: Q1, 2017 By the Numbers : May 24, 2017

    Categories: Yahoo FinanceGet free summary analysis Nymox Pharmaceutical Corp. reports financial results for the quarter ended March 31, 2017. We analyze the earnings along side the following peers of Nymox Pharmaceutical Corp. – Abbott Laboratories, Eli Lilly and Company, Quest Diagnostics Incorporated, Pfizer Inc., Johnson & Johnson and Sophiris Bio Inc. (ABT-US, LLY-US, DGX-US, PFE-US, JNJ-US and ... Read more (Read more...)

  • Associated Press2 months ago

    Nymox reports 1Q loss

    On a per-share basis, the Nassau, Bahamas-based company said it had a loss of 6 cents. The biopharmaceutical company posted revenue of $78,400 in the period. Its adjusted revenue was $78,000. The company's ...